Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00583180
Other study ID # 4975-2008-01
Secondary ID
Status Completed
Phase N/A
First received December 20, 2007
Last updated January 29, 2008
Start date January 2008
Est. completion date January 2008

Study information

Verified date January 2008
Source Rigshospitalet, Denmark
Contact n/a
Is FDA regulated No
Health authority Denmark: Danish Dataprotection AgencyDenmark: Ethics Committee
Study type Observational

Clinical Trial Summary

The use of capsaicin as a potential analgesic drug for postoperative pain relies on the ability of capsaicin to induce membrane lysis of c-nerve fibers. In a previous randomized placebo controled blinded study of this effect we found a significant effect of capsaicin versus placebo. Before surgery all patients were examined by quantitative sensory testing to evaluate sensory function. In this study an identical sensory testing will examine if changes to the sensory function in capsaicin treated patients is identical to placebo treated patients.No new intervention will be performed


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date January 2008
Est. primary completion date
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Primary groin hernia planned to undergo Lichtenstein mesh repair

- Ability to use pain scales

- American Society of Anesthesiologist class I or II based upon medical history, physical examination, and screening laboratory results

- Willing to take oral pain medication (acetaminophen, ibuprofen) for the first week

- Willing to fill out a diary for four weeks following surgery.

Exclusion Criteria:

- A previous lower abdominal surgical procedure

- Bupivacaine, acetaminophen, ibuprofen, or tramadol

- A medical condition likely to alter wound healing or pain ratings

- Systolic blood pressure greater than 150 or diastolic greater than 95 mm Hg

- Contraindication to general anesthesia

- Bilateral hernia repair

- A history of drug or alcohol abuse within the past two years

- Use of antihypertensive, antidepressant, or psychotropic drug that has not been stable for 3 months

- Use of an investigational drug within 3 months or scheduled to receive an investigational drug other than ALGRX 4975 during the study period.

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Drug:
Capsaicin
instillation of sterile water or 1000 micrograms of capsaicin into the wound at the end of open groin hernia surgery in previous study.no new intervention will be performed in the current study.

Locations

Country Name City State
Denmark Hørshol Sygehus Hørsholm

Sponsors (1)

Lead Sponsor Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary changes in sensory function before and 2 years after groin hernia repair in patients with and without capsaicin instillation, evaluated by quantitative sensory testing 2 years Yes
Secondary Frequency of chronic pain 2 years Yes